Novo Nordisk Is A Danish Multinational Pharmaceutical Company That Specializes In Developing And Manufacturing Medications For Diabetes Careobesity Carehaemophilia Careand Rare Endocrine Disordersfounded In 1989 Through The Merger Of Nordisk Insulinlaboratorium And Novo Terapeutisk Laboratoriumthe Company Has Roots Dating Back To The 1920S When It Began Producing Insulin As The World S Largest Producer Of Insulinnovo Nordisk Offers A Variety Of Insulin Productsincluding Novologlevemirand Tresibathe Company Is Also Recognized For Its Glp 1 Receptor Agonistssuch As Ozempic And Wegovywhich Are Used To Treat Type 2 Diabetes And Obesityadditionallynovo Nordisk Provides Treatments For Haemophiliaincluding Novoseven And Novoeightthe Company Is Dedicated To Addressing Global Health Challenges Through Innovative Therapies And Operates Under A Framework That Emphasizes Collaboration And Commitment To Defeating Serious Chronic Diseases
No conferences found for this company.
| Company Name | Novo Nordisk Pharma Co Ltd |
| Country |
Japan
|
| Address | 13f Meiji Yasuda Seimei Bldg 211 Marunouchi Chiyoda Ku 100 0005 Japan |
| Telephone | Login to View |
| Login to View |
